A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance

Treatment options for advanced gallbladder cancer (GBC) are scarce and usually rely on cytotoxic chemotherapy, but the effectiveness of any regimen is limited and recurrence rates are high. Here, we investigated the molecular mechanisms of acquired resistance in GBC through the development and chara...

Descripción completa

Detalles Bibliográficos
Autores principales: Vergara-Gómez, Luis, Bizama, Carolina, Zhong, Jun, Buchegger, Kurt, Suárez, Felipe, Rosa, Lorena, Ili, Carmen, Weber, Helga, Obreque, Javiera, Espinoza, Karena, Repetto, Gabriela, Roa, Juan C., Leal, Pamela, García, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139168/
https://www.ncbi.nlm.nih.gov/pubmed/37108401
http://dx.doi.org/10.3390/ijms24087238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10139168/
https://www.ncbi.nlm.nih.gov/pubmed/37108401
http://dx.doi.org/10.3390/ijms24087238

Ejemplares similares